Tumor-specific viruses regulatory update

Calydon received U.S. Patents Nos. 6,057,299; 6,051,417; and 6,136,792 covering a human prostate-specific antigen enhancer (PSE) and a human glandular kallikrein enhancer (GKE) that regulate express...